X Financial Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Stock Information for Northwest Biotherapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Northwest Biotherapeutics Inc

X Financial (NYSE: XYF) Reports Q3 2025 Results: Revenue +23.9% YoY, Sequential Decline Amid Rising Credit Costs and Moderating Borrower Activity
X Financial to Hold Annual General Meeting on December 18, 2025
X Financial to Report Third Quarter 2025 Financial Results on November 21, 2025
X Financial (NYSE: XYF) Reports Q2 2025 Results: Revenue +66%, Record Loan Originations, Improved Asset Quality
X Financial to Report Second Quarter 2025 Financial Results on August 19, 2025
X Financial Reports First Quarter 2025 Unaudited Financial Results
X Financial to Report First Quarter 2025 Financial Results on May 20, 2025
X Financial Files Annual Report on Form 20-F for Fiscal Year 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.